Description
Acne can affect teenagers and adults alike, and an effective acne cleanser is an essential step in any anti-acne skincare regimen. Ideal for daily use to gently exfoliate the dead skin cells that can clog pores and contribute to acne, a cleanser with salicylic acid offers acne-controlling benefits and may complement other over-the-counter and prescription-based acne treatments to help maintain clear, healthy skin—just be sure to check with your dermatologist.
CeraVe is the #1 dermatologist-recommended cleanser brand for acne*, and our new Acne Control Cleanser with 2% salicylic acid is formulated to clear acne, reduce blackheads and improve the appearance of pores, while purifying clay helps absorb excess oil. Featuring Oil-Absorbing Technology to minimize visible shine, this refreshing, gel-to-foam salicylic acid cleanser effectively removes dirt and excess oil, gently exfoliates and penetrates clogged pores to help prevent new acne breakouts. Acne Control Cleanser also maintains the skin’s protective barrier with 3 essential ceramides, calms the skin with niacinamide and reduces acne while leaving the skin soft, smooth and hydrated.
BENEFITS:
Oil-Absorbing Technology
Minimizes visible shine
Non-Comedogenic
Won’t clog pores
Fragrance Free
Fragrance-free formula
Paraben Free
Formulated without Parabens to be gentle on skin
Hectorite Clay
Helps Absorb oil and helps skin look less shiny
INGREDIENTS:
Ceramides: Helps restore your skin’s natural barrier, helping to keep moisture in and harmful elements out.
Salicylic Acid: Promotes the skin’s natural exfoliation process, which helps skin feel softer and smoother.
Niacinamide: May help calm skin, reduce transepidermal water loss (TEWL), and increase moisture in skin’s uppermost layer.
HOW TO USE:
1. Use every morning and evening
2. Wet face, then work a dime-size amount into a lather
3. Gently massage, avoiding the eye area
4. Rinse well
When
Time of Day: ANYTIME
Routine Order: Cleanse- Tone – Treat – Moisturize – Protect
Where: Face
Reviews
There are no reviews yet.